1. Icre G, Wahli W, Michalik L. Functions of the peroxisome proliferator-activated receptor (PPAR) alpha and beta in skin homeostasis, epithelial repair, and morphogenesis. J Investig Dermatol Symp Proc. 2006 Sep;11(1):30-5. 2. Dubrac S, Schmuth M. PPAR-alpha in cutaneous inflammation...
PPAR是一种在细胞内核中发现的转录因子，属于配体激活的转录因子超家族。它参与调节与能量代谢相关的基因表达，如脂肪储存、胰岛素抵抗等。在生理条件下，PPAR的激活对于维持正常的细胞功能和代谢平衡起着重要作用。二、功能特点 PPAR有三种亚型：PPARα、PPARβ/δ和PPARγ。每种亚型都...
specific to Human PPAR alpha 偶联物 Unconjugated 形式 Liquid 浓度 0.25 mg/mL 纯化类型 Affinity chromatography 保存液 PBS, pH 7.4 内含物 0.1% sodium azide 保存条件 -20°C 运输条件 Ambient (domestic); Wet ice (international) RRID AB_2533525 靶标信息 Peroxisome prolif...
抗体名: PPAR alpha 浓度: 见爱必信官网 % 靶点: 见爱必信官网 宿主: 见爱必信官网 应用范围: 见爱必信官网 产地: 中国 品牌: 爱必信(absin) 货号: abs124681 亚型: 见爱必信官网 是否单克隆: 否 免疫原: 见爱必信官网 包装规格: 50ul,100ul 适应物种: 见爱必信官网 克隆性: 见爱必信官网 ...
F.J., Zakany, J., Metzger, D., Chambon, P., Duboule, D. and Wahli, W. (2001). Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. The Journal of Cell Biology, [online] 154(4), pp.799–814. doi:10.1083/jcb.200011148. ...
中文名称:α型-过氧化酶活化增生受体抗体(PPAR α, PPAR-α)Anti-PPAR alpha 英文名称:Anti-PPAR alpha 别名: hPPAR; MGC2237; MGC2452; NR1C1; Nuclear receptor subfamily 1 group C member 1; Peroxisome Proliferator Activated Receptor alpha; PPAR; PPAR alpha; PPARA. ...
Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity[J]. Hepatology,2010,51(2):511-22. [16] Shan W,Nicol C J,Ito S,et al. Peroxisome proliferator-activated receptor-beta/delta protects against chemically ...
网络释义 1. 激活核受体 换句话说,单元不饱合的FAE,经由激活核受体(PPAR-alpha),以降低摄取食物量和降低体重增加的功能。在近期的报告中,我们研究 …tw.myblog.yahoo.com|基于3个网页 例句 释义: 全部,激活核受体 更多例句筛选 1. This is a mechanism mediated via PPAR alpha or for example as the ...
proliferators-activated receptors (PPAR) alpha enhanced the multiple organ failure induced by zymosan[J]. Shock, 2006, 26(5): 477-484. DOI: 10.1097/01.shk.0000230299.78515.2c. [6] Sheu MY, Fowler AJ, Kao J, et ...